Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Science & Health
Feb 28, 2023
Japan health ministry panel endorses nasal flu vaccine for children
Based on the results of a clinical trial involving children in Japan, the panel agreed that FluMist Quadrivalent is safe and effective in preventing the flu.
Japan Times
BUSINESS / Companies
Feb 27, 2023
Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
CEO Isao Teshirogi said he expects U.S. approval of the drug could come by the winter of 2024, pending a late-stage trial.
Japan Times
COMMENTARY / World
Feb 27, 2023
A refreshing gamble on Crispr delivery
Biotech startup Aera is trying to shake up the always-just-out-of-reach field of genetic medicine.
Japan Times
JAPAN / Explainer
Feb 27, 2023
Japan moves toward approving abortion pill in major shift
Currently, surgery is the only option available to terminate a pregnancy in Japan.
JAPAN / Science & Health
Feb 22, 2023
Shionogi says its drug Xocova may reduce risks of long COVID symptoms
For 14 major symptoms of COVID-19, 14.5% of those given Xocova reported at least one of the symptoms six months after the start of treatment, compared with 26.3% who were given a placebo.
Japan Times
COMMENTARY / Japan / Geoeconomic Briefing
Feb 21, 2023
Why pharmaceuticals are a key issue in the ongoing U.S.-China conflict
Beijing has control over the chokepoints — active pharmaceutical ingredients and raw materials — of pharmaceutical supply chains.
Japan Times
JAPAN
Jan 30, 2023
Priority review status given to Alzheimer's drug developed by Eisai and Biogen
The companies said priority review in Japan is granted to new medicines recognized as having high medical utility for serious diseases.
Japan Times
JAPAN / Science & Health
Jan 27, 2023
Abortion pill gets OK from Japan government panel in major step toward final approval
Abortion is legal in Japan up to 22 weeks, but a surgical procedure is currently the only option available for women and consent is usually required from a spouse or partner.
Japan Times
ASIA PACIFIC
Jan 16, 2023
In China, no easy way to get Pfizer's COVID drug Paxlovid
Beijing has acknowledged that supplies are still insufficient to meet demand, even as millions of courses of the treatment were shipped to the country recently.
Japan Times
WORLD / Science & Health
Jan 14, 2023
Pfizer's bivalent vaccine linked to rare strokes in older people in preliminary U.S. data
The early finding still needs more investigation, and recommendations for the vaccine have not been changed, a statement by the U.S. Food and Drug Administration said.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
JAPAN
Jan 11, 2023
Health ministry suggests restricting bulk drug purchases amid hoarding fears
The message follows reports of Chinese people in the country buying medicine in bulk and mailing it to friends and families back home.
Japan Times
BUSINESS / Markets
Jan 10, 2023
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab
The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.
Japan Times
ASIA PACIFIC / Science & Health
Jan 7, 2023
China in talks with Pfizer for generic COVID drug
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.
Japan Times
BUSINESS / Companies
Jan 6, 2023
Shionogi's COVID-19 pill may get China approval in March
The Japanese drugmaker has been submitting data to regulators in China and expects Xocova to be authorized for use as early as this quarter, Chief Executive Officer Isao Teshirogi said.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
ASIA PACIFIC
Dec 30, 2022
China's COVID wave sparks scramble for vital drugs across Asia
Beijing's decision to abruptly remove most pandemic restrictions with little preparation is driving an unprecedented number of cases, leaving hospitals and funeral homes overwhelmed.
Japan Times
BUSINESS / Companies
Dec 28, 2022
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough
Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer's biomarkers in blood tests.
Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer’s
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
WORLD / Science & Health
Dec 22, 2022
Injectable HIV treatment offers hope to Ugandan patients
Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji